Why Quanterix Corporation’s (QTRX) Stock Is Down 5.07%
As of Thursday, July 16, Quanterix Corporation’s QTRX share price has dipped by 5.07%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company’s products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Commentary & Analysis
Why Quanterix Corporation’s (QTRX) Stock Is Down 5.50%
As of Wednesday, July 08, Quanterix Corporation’s QTRX share price has dipped by 5.50%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Quanterix Corporation’s (QTRX) Stock Is Down 7.05%
As of Tuesday, June 30, Quanterix Corporation’s QTRX share price has dipped by 7.05%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Quanterix Corporation’s (QTRX) Stock Is Up 10.37%
As of Friday, June 26, Quanterix Corporation’s QTRX share price has surged by 10.37%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Quanterix Corporation’s (QTRX) Stock Is Up 7.61%
As of Wednesday, June 24, Quanterix Corporation’s QTRX share price has surged by 7.61%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | QTRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $165.8 | $1,774.7 | 26% |
|
| Shares Out (Mil) | 47.0 | 94.8 | 46% |
|
| Institutional Ownership | 91.0% | 90.1% | 59% |
|
| Float (Mil) | 38.5 | 69.9 | 42% |
|
| Beta | 1.15 | 1.20 | 68% |
|
| Avg Daily Volume (000s) | 458 | 838 | 58% |
|
| Price Change (52-week) |
(42.1%) | 81.0% | 19% |
|
| Growth | QTRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.0% | 7.8% | 58% |
|
| Net Income (5yr) | (27.8%) | (13.7%) | 15% |
|
| EPS (5yr) | (18.7%) | 0.7% | 14 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.6%) | (15.0%) | 39% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | ($0.410) | ($1.290) | ($1.323) | |
| Month Ago EPS | na | na | na | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.560) | ($2.080) | ($1.910) | |
| Year/Year Chg | 9.9% | (48.7%) | (55.2%) | |
| Financials | QTRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $145 | $763 | 29% |
|
| Net Income (TTM) (Mil) | ($104) | ($14) | 10% |
|
| EPS (TTM) | ($2.331) | ($0.200) | 13% |
|
| Operating Cash Flow (TTM) (Mil) | ($82) | $53 | 7% |
|
| Net Cash Flow (TTM) (Mil) | ($40) | ($5) | 21% |
|
| Long-Term Debt (Q1) (Mil) | $27 | $270 | 34% |
|
| Enterprise Value (Q1) (Mil) | $72 | $2,430 | 19% |
|
| Valuation | QTRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.59 | 3.00 | 11% |
|
| P/E | na | 43.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 5.3 | na |
|
| Ratios | QTRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 45.3% | 47.6% | 57% |
|
| Net Margin | (71.9%) | (2.9%) | 9% |
|
| ROA | (27.3%) | (3.2%) | 18% |
|
| ROE | (34.8%) | (4.5%) | 19% |
|
| Liabilities to Assets | 23.1% | 43.0% | 15% |
|
| F-Score | 3 | 5 | 19% |
|
Quanterix Corporation did not pass any screens on 7/30/2026.
